UY34719A - Proceso para la producción de inhibidores de crr - Google Patents

Proceso para la producción de inhibidores de crr

Info

Publication number
UY34719A
UY34719A UY0001034719A UY34719A UY34719A UY 34719 A UY34719 A UY 34719A UY 0001034719 A UY0001034719 A UY 0001034719A UY 34719 A UY34719 A UY 34719A UY 34719 A UY34719 A UY 34719A
Authority
UY
Uruguay
Prior art keywords
crr
inhibitors
production
pág
escanear
Prior art date
Application number
UY0001034719A
Other languages
English (en)
Spanish (es)
Inventor
Duran Adil
Schmid Rolf
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of UY34719A publication Critical patent/UY34719A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
UY0001034719A 2012-04-02 2013-04-02 Proceso para la producción de inhibidores de crr UY34719A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12162852 2012-04-02

Publications (1)

Publication Number Publication Date
UY34719A true UY34719A (es) 2013-10-31

Family

ID=47998462

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001034719A UY34719A (es) 2012-04-02 2013-04-02 Proceso para la producción de inhibidores de crr

Country Status (9)

Country Link
US (1) US8680280B2 (https=)
EP (1) EP2834229B1 (https=)
JP (1) JP6255550B2 (https=)
AR (1) AR090566A1 (https=)
DK (1) DK2834229T3 (https=)
ES (1) ES2641862T3 (https=)
TW (1) TW201400474A (https=)
UY (1) UY34719A (https=)
WO (1) WO2013149926A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8278302B2 (en) 2009-04-08 2012-10-02 Boehringer Ingelheim International Gmbh Substituted piperidines as CCR3 antagonists
UA109290C2 (uk) 2010-10-07 2015-08-10 Спільні кристали і солі інгібіторів ccr3
AR090566A1 (es) 2012-04-02 2014-11-19 Boehringer Ingelheim Int Proceso para la produccion de inhibidores de crr
US10213421B2 (en) 2012-04-04 2019-02-26 Alkahest, Inc. Pharmaceutical formulations comprising CCR3 antagonists
MY199462A (en) 2017-04-05 2023-10-30 Alkahest Inc Methods and compositions for treating retina-associated disease using ccr3-inhibitors
SG11201909245PA (en) 2017-04-05 2019-11-28 Alkahest Inc Methods and compositions for treating aging-associated impairments using ccr3-inhibitors
MY198220A (en) 2018-05-15 2023-08-14 Alkahest Inc Treatment Of Aging-Associated Disease With Modulators Of Leukotriene A4 Hydrolase
AU2021287906B2 (en) 2020-06-11 2025-09-11 Alkahest Inc. Methods of improving retina-associated disease outcome using CCR3-inhibitors
AU2022376563A1 (en) 2021-11-01 2023-12-07 Alkahest, Inc. Benzodioxane modulators of leukotriene a4 hydrolase (lta4h) for prevention and treatment of aging-associated diseases

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7907121L (sv) 1979-08-27 1981-02-28 Astra Laekemedel Ab Ftalimidinderivat
JP2807577B2 (ja) 1990-06-15 1998-10-08 エーザイ株式会社 環状アミド誘導体
JPH08134041A (ja) * 1994-11-10 1996-05-28 Fuji Photo Film Co Ltd ピラゾールアミド類の製造方法
US6433165B1 (en) 1998-01-21 2002-08-13 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
WO1999038514A1 (en) 1998-02-02 1999-08-05 Merck & Co., Inc. Cyclic amine modulators of chemokine receptor activity
US6140349A (en) 1998-02-02 2000-10-31 Merck & Co., Inc. Cyclic amine modulators of chemokine receptor activity
EP1725235B1 (en) 2004-02-05 2009-04-15 Schering Corporation Piperidine derivatives useful as ccr3 antagonists
JP2006137718A (ja) 2004-11-12 2006-06-01 Astellas Pharma Inc インドール若しくはインダゾール誘導体
US8030003B2 (en) 2004-12-07 2011-10-04 Children's Hospital Medical Center Diagnosis of eosinophilic esophagitis based on presence of an elevated level of eotaxin-3
DOP2006000051A (es) 2005-02-24 2006-08-31 Lilly Co Eli Inhibidores de vegf-r2 y métodos
US20090124636A1 (en) 2006-04-12 2009-05-14 Pfizer Inc. Chemical compounds
GB0701992D0 (en) 2007-02-02 2007-03-14 7Tm Pharma As Grehlin Receptor Modulators
US8008092B2 (en) 2007-10-09 2011-08-30 University Of Kentucky Research Foundation CCR3 inhibition for ocular angiogenesis and macular degeneration
TW201000446A (en) 2008-05-30 2010-01-01 Astrazeneca Ab New compounds useful in pain therapy
US8278302B2 (en) 2009-04-08 2012-10-02 Boehringer Ingelheim International Gmbh Substituted piperidines as CCR3 antagonists
UA109290C2 (uk) 2010-10-07 2015-08-10 Спільні кристали і солі інгібіторів ccr3
AR090566A1 (es) 2012-04-02 2014-11-19 Boehringer Ingelheim Int Proceso para la produccion de inhibidores de crr
US20130261153A1 (en) 2012-04-03 2013-10-03 Boehringer Ingelheim International Gmbh Use of ccr3-inhibitors
US10213421B2 (en) 2012-04-04 2019-02-26 Alkahest, Inc. Pharmaceutical formulations comprising CCR3 antagonists

Also Published As

Publication number Publication date
JP2015516959A (ja) 2015-06-18
TW201400474A (zh) 2014-01-01
JP6255550B2 (ja) 2018-01-10
US8680280B2 (en) 2014-03-25
EP2834229B1 (en) 2017-08-09
ES2641862T3 (es) 2017-11-14
WO2013149926A1 (en) 2013-10-10
US20130261307A1 (en) 2013-10-03
DK2834229T3 (da) 2017-11-20
AR090566A1 (es) 2014-11-19
EP2834229A1 (en) 2015-02-11

Similar Documents

Publication Publication Date Title
UY34763A (es) Inhibidores de la agregación plaquetaria
UY34472A (es) Derivados modificados de 4-fenil-piridina
UY34550A (es) Bencilpirazoles sustituidos
UY34467A (es) Procedimiento para la preparación de 5-fluoro-1h-pirazolopiridinas sustituidas
UY34145A (es) Compuestos inhibidores de metaloenzimas
UY34146A (es) Compuestos inhibidores de metaloenzimas
UY34719A (es) Proceso para la producción de inhibidores de crr
UY33925A (es) Inhibidores tricíclicos de quinasas
UY34591A (es) Compuestos de imidazopirrolidinona
UY34559A (es) Inhibidores de bromodominios
MX378288B (es) Inhibidores de pirimidina del fgfr4.
UY34374A (es) Benzilindazoles sustituidos
UY34648A (es) Amidas como inhibidores de pim
UY34201A (es) Compuestos de azaindol y métodos para el tratamiento de vih.
UY34660A (es) Inhibidores de benzodioxano de la producción de leucotrieno
UY34657A (es) ?derivados macrocíclicos para el tratamiento de enfermedades?.
UY34393A (es) Compuestos de tetrahidroisoquinolina sustituidos como inhibidores del factor xia
UY34541A (es) ?derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina?.
UY34108A (es) ?proceso para la fabricación de sustratos revestidos?.
UY34817A (es) Tienopirimidinas
UY34767A (es) Inhibidores cíclicos del enlace éter de dgat1
UY34523A (es) Derivados de betulina
UY34034A (es) Triazolopiridinas
UY34661A (es) Inhibidores de benzodioxano de la producción de leucotrieno para terapia de combinación
AR095075A1 (es) Acoplamiento electroquímico de anilinas